Non-Opioid Pain Relief Device Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Non-opioid drugs and therapies, such as physical therapy, are ineffective for some people with chronic pain. New therapies are being developed for them that may relieve their pain and, in some cases, prevent it from returning. Some of the latest technologies for relieving chronic pain include electroanalgesia, radiofrequency ablation, and Others. These technologies use implantable devices and non-implantable devices for treatments. Minimally invasive surgery, as well as other invasive and non-invasive pain management modalities like spinal cord stimulators, implantable intraspinal drug infusion pumps, cooled and standard radiofrequency neuroablation, electromagnetic energy, digital therapeutics, vertebral augmentation, ultrasound-guided regional anesthesia, and portable continuous pain relief systems, are examples of non-opioid treatments.
MARKET DYNAMIC
Factors driving the growth of the non-opioid pain relief device market are the growing pain incidences in the geriatric population, coupled with rising adoption of sedentary lifestyle leading to increased burden of chronic pain. However, the limited awareness regarding products available as well as the burden of product recalls is expected to hamper the growth of the market. Moreover, the limited success rate of drugs targeting pain disorders and the high number of side effects of the opioid drugs are anticipated to boost the market growth.

MARKET SCOPE

The "Non-Opioid Pain Relief Device Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of non-opioid pain relief device market with detailed market segmentation by technology, application, and end user. The non-opioid pain relief device market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in non-opioid pain relief device market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The non-opioid pain relief device market is segmented on the basis of technology, application, and end user. Based on technology, the market is segmented as electroanalgesia, radiofrequency ablation, and other emerging technologies. Electroanalgesia is sub segmented as implantable device and non-implantable device. Non-implantable device sub segmented as traditional tens, wearable tens, and others. On the basis of application, the market is categorized as neuromuscular, musculoskeletal, diabetic neuropathy, injuries, and others. On the basis of end-user, the market is categorized as hospitals, pain management centers, and homecare

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the non-opioid pain relief device market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-opioid pain relief device market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting non-opioid pain relief device market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-opioid pain relief device market in these regions.

MARKET PLAYERS

The report covers key developments in the non-opioid pain relief device market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from non-opioid pain relief device market are anticipated to have lucrative growth opportunities in the future with the rising demand for non-opioid pain relief device in the global market. Below mentioned is the list of few companies engaged in the non-opioid pain relief device market.

The report also includes the profiles of key players in non-opioid pain relief device market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•   Abbott Laboratories
  
•   Medtronic plc
  
•   Boston Scientific Corporation
  
•   Koninklijke Philips N.V.
  
•   Stryker
  
•   Nuvectra Corporation
  
•   Omron Corporation
  
•   Neurometrix, Inc
  
•   Calmare Therapeutics Incorporated
  
•   Bayer AG
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Non-Opioid Pain Relief Device Report Scope